Biotechnology Investments

Biotechnology Investments Ltd., formerly known as BSP Biological Signal Processing Ltd., is an Israeli company operating in the technology sector. The company provides products for the non-invasive diagnosis and monitoring of coronary artery disease (CAD). Its product portfolio includes: HyperQ EX-300, a 12-lead stress electrocardiogram (ECG) system capable of analyzing high-frequency components of ECG signals (HyperQ analysis); HyperQ AD-100, a system integrated with traditional stress ECG machines to provide HyperQ CAD analysis; and HyperQ AN-S OEM products, which enable any ECG data acquisition system to enhance its diagnostic capabilities by incorporating HyperQ analysis. HyperQ technology employs a multifaceted process to interpret information acquired from ECG hardware.